Ann: Consumer Mental Health App Development - Second Test Phase, page-3

Our patience continues to be tested. I sent the company an email yesterday. Below is the reponse I got from them:

"Thank you for your email and support of Medibio Ltd.

I have attached for your information our latest investor deck that will provide you with a good summary of the Company's business operations and also the major milestones that we are working towards.

Unfortunately, we are prohibited by the law and ASX regulations to inform any one shareholder or investor of information that is not also available to the wider market and investment community. What we are able to do however is direct you to some of the more recent announcements regarding the regulated and unregulated business units here:

https://medibio.com.au/asx-announcements/

Also, we will shortly be making further announcements regarding our Consumer App and our FDA strategy for MEBsleep and also releasing our Quarterly Report by the end of April.

Finally if I may, I am pleased to advise that the Company is making good progress not only on the regulated side of the business but also with our corporate product, ilumen, which is receiving very positive market feedback; and the development of our consumer stress app, which will be launched later this year. We hope to be informing the market on all fronts in the coming weeks.

Once again, thank you for your enquiry and your continuing support of Medibio Ltd.

Warm regards,

Renee Stanton-Horne
Operations and Account Manager"